Sign in Create account

Nectar Lifesciences Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: NECLIFE BSE: 532649
₹10.50
▼ -0.21 (-1.96%)
Sept. 30, 2026 · NSE · nse_bhavcopy
Quality
22/100
Weak
Valuation
84/100
Undervalued
Momentum
12/100
Bearish

QVM read Cheap on its own multiples Quality Weak, Valuation Undervalued, Momentum Bearish

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹204 Cr
PE (TTM)
22.3
Industry median 36.1 (152 companies)
Price to Book
0.4
PEG (TTM)
0.2
Institutions holding %
4.24%
FII + DII, latest filed period
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
-1.9
Relative return vs Sector, qtr %
-9.3
Free Cash Flow
₹-361 Cr
as of March 31, 2026
Industry median ₹-0 Cr (198 companies)
EPS Growth (YoY)
75.53%
as of June 30, 2026
Industry median 26.14% (180 companies)
Net Profit Growth (TTM)
0.00%
as of June 30, 2026
Industry median 6.21% (175 companies)
Operating Revenue Growth (TTM)
-55.07%
as of June 30, 2026
Industry median 9.08% (175 companies)
Profit Growth (YoY)
400.32%
as of Dec. 31, 2024
Industry median 22.20% (176 companies)
Revenue Growth (YoY)
-99.99%
as of June 30, 2026
Industry median 14.05% (173 companies)
Current Ratio
9.71
as of March 31, 2026
Industry median 1.84 (197 companies)
Debt to Equity
0.00
as of March 31, 2026
Industry median 0.14 (186 companies)
Interest Coverage
0.38
as of June 30, 2026
Industry median 10.58 (182 companies)
Net Margin
1.72%
as of Dec. 31, 2024
Industry median 9.35% (179 companies)
Operating Margin (EBIT)
-143320.67%
as of June 30, 2026
Industry median 14.22% (181 companies)
Operating Margin (TTM)
1.93%
as of June 30, 2026
Industry median 12.41% (182 companies)
Return on Assets
-47.12%
as of March 31, 2026
Industry median 5.54% (180 companies)
Return on Capital Employed
-7.18%
as of March 31, 2026
Industry median 12.43% (181 companies)
Return on Equity
-50.30%
as of March 31, 2026
Industry median 9.66% (179 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

2 of 6 met
  • No Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • Yes Debt to equity is below 0.5 (0.00)
  • No Return on equity is 15% or more (-50.3%)
  • Yes Net cash flow for the latest year is positive
  • No Cash from operations is higher than the year before

Ownership

3 of 4 met
  • No FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)
  • Yes Insiders have not sold in the past 3 months (no open-market sale filed in the last 3 months)

Peer comparison

1 of 3 met
  • No 1-year return beats the industry median
  • No Revenue growth beats the industry median
  • Yes Profit growth beats the industry median

Value and momentum

2 of 6 met
  • Yes Price sits in the Buy zone of its own historical PE range (Undervalued (below its own historical PE range))
  • Yes Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-2.0%
Low 10.3000 · High 10.9500
1W return
-5.1%
Low 10.3000 · High 11.2000
1M return
-16.3%
Low 10.3000 · High 12.7400
52W return
-25.6%
Low 9.3000 · High 22.4000
Lifetime High ₹376.3000 (Aug. 22, 2008)
Lifetime Low ₹7.4500 (March 23, 2020)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish0
Bearish6
5D
10.7
10D
10.9
20D
11.1
50D
11.3
100D
11.7
200D
12.8

Delivery and volume

Day avg. delivery
62.9%
Week avg. delivery
70.8%
Month avg. delivery
75.3%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

10.58
Pivot
First resistance10.87
Second resistance11.23
Third resistance11.52
First support10.22
Second support9.93
Third support9.57
Day RSI35.9
Day MFI11.0
Day MACD-0.22
Day MACD signal-0.11

Beta

1M0.34
3M0.32
1Y1.04
3Y0.99

Price change analysis

↓ -16.3%
Over 1 Month
LowHigh
10.3012.74
↓ -9.3%
Over 3 Months
LowHigh
9.9813.50
↑ 7.6%
Over 6 Months
LowHigh
9.7114.91
↓ -25.6%
Over 1 Year
LowHigh
9.3022.40
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 22.3 (own history: 24.6–131.1)
Undervalued (below its own historical PE range)

Financials

View full financials, peers & valuation multiples →
Revenue (June 30, 2026)
₹0 Cr
Net profit (June 30, 2026)
₹-13 Cr
Basic EPS (June 30, 2026)
₹-0.6900

Ranks #117 of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter51.84%
  • FII/FPI0.50%
  • Other DII3.74%
  • Public43.92%

Largest holders

NameCategoryShares %Shares
SANJIV GOYALPromoter24.6300%47845600
SANJIV (HUF) - KARTA SANJIV GOYALPromoter22.4600%43622400
RAMAN GOYALPromoter4.7600%9238448
RAJASTHAN GLOBAL SECURITIES PRIVATE LIMITEDPublic3.7300%7247763

As of June 30, 2026. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings were unchanged at 51.84% in Jun 2026 qtr

Historical fii holding

FII/FPI holdings decreased from 0.60% to 0.50% in Jun 2026 qtr

Historical mutual fund holding

Mutual funds holdings were unchanged at 0.00% in Jun 2026 qtr

All shareholding details →

Insider trading, SAST & pledges

All 27 insider trades, 17 SAST, 13 pledge events →

Latest insider trades

FiledPersonCategoryTypeQuantityValue
28 Nov 2025 Raman Goyal Promoter Buy 0 ₹0
28 Nov 2025 Sanjiv Goyal Promoter Sell 0 ₹0
4 Nov 2025 SBICAP Trustee Company Limited Other Pledge Revoke 0 ₹92.37 Cr
30 Oct 2025 Sanjiv Goyal Promoter Pledge Revoke 0 ₹88.01 Cr
30 Oct 2025 Sanjiv Goyal Promoter Pledge Revoke 0 ₹88.01 Cr
30 Oct 2025 Sanjiv(HUF) Promoter Pledge Revoke 0 ₹68.75 Cr
30 Oct 2025 Sanjiv HUF Promoter Pledge Revoke 0 ₹68.75 Cr
19 Dec 2024 RAMAN GOYAL Promoter group Buy 0 ₹0
3 Jun 2021 SBICAP Trustee Company Ltd. Other Pledge 0 ₹308.85 Cr
1 Jun 2021 Sanjiv HUF Promoter Pledge 0 ₹135.45 Cr

All insider and SAST disclosures →

Deals (Bulk & Block)

All 86 deals, with filters and CSV →
DateClientDealActionQuantityPriceExchange
4 Dec 2025 MARWADI CHANDARANA INTERMEDIARIES BROKERS PRIVATE LIMITED Bulk Buy 1,500,000 20.9300 NSE
4 Dec 2025 JAIDEEP SAMPAT Bulk Sell 1,695,746 20.5400 NSE
4 Dec 2025 IRAGE BROKING SERVICES LLP Bulk Sell 1,479,033 20.4700 NSE
4 Dec 2025 IRAGE BROKING SERVICES LLP Bulk Buy 800,112 20.4800 NSE
4 Dec 2025 ANKITA VISHAL SHAH Bulk Sell 1,349,525 20.6500 NSE
4 Dec 2025 ANKITA VISHAL SHAH Bulk Buy 1,349,525 21.0100 NSE
8 Jul 2025 TRADELINK INVESTMENTS Bulk Sell 1,859,823 20.6000 NSE
8 Jul 2025 SHARE INDIA SECURITIES LIMITED Bulk Buy 1,695,302 19.5800 NSE
8 Jul 2025 SHARE INDIA SECURITIES LIMITED Bulk Sell 1,630,329 19.0500 NSE
8 Jul 2025 QUARKS TECHNOSOFT PRIVATE LIMITED Bulk Sell 1,635,000 19.0600 NSE

All bulk and block deals →

Dividends

Full dividend history →
Ex-dateSubjectPer share (₹)Record date
11 Sep 2020 Annual General Meeting/Dividend - Rs 0.05 Per Share 0.0500 —
19 Sep 2019 Annual General Meeting/Dividend - Rs 0.05 Per Share 0.0500 —
19 Sep 2018 Annual General Meeting/Dividend- Re 0.05 Per Share 0.0500 —
20 Sep 2017 Annual General Meeting/Dividend - Re 0.05 Per Share 0.0500 —
22 Sep 2016 Annual General Meeting/Dividend - Re 0.10 Per Share 0.1000 —
22 Sep 2015 Annual General Meeting/ Dividend - Re 0.10/- Per Share 0.1000 —
21 Aug 2014 Annual General Meeting / Final Dividend - Re 0.10/- Per Share 0.1000 —
19 Sep 2013 Annual General Meeting And Dividend Re.0.10 Per Share 0.1000 —
20 Sep 2012 Annual General Meeting And Dividend Re.0.10 Per Share 0.1000 —
21 Sep 2011 Annual General Meeting And Dividend Re.0.10 Per Share 0.1000 —

Corporate Actions

Full history (22 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
12 Nov 2008SPLITFv Split Rs.10/- To Re.1/
24 Dec 2025BUYBACKBuy Back
13 Sep 2024OTHERAnnual General Meeting
14 Sep 2023OTHERAnnual General Meeting
13 Sep 2022OTHERAnnual General Meeting
13 Sep 2021OTHER Annual General Meeting

All corporate actions →

Board Meetings

View board meeting history →

Quarterly results, AGMs, buybacks and other board-approved business.

DatePurposeResults
14 Aug 2026 Financial Results/Other business matters Yes
30 May 2026 Financial Results/Other business matters Yes
23 Jan 2026 Financial Results/Other business matters Yes
3 Dec 2025 Buyback/Other business matters —
14 Nov 2025 Financial Results/Other business matters Yes

Corporate Announcements

All 524 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
3 Oct 2026 Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company Nectar Lifesciences Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
3 Oct 2026 Company Update Nectar Lifesciences Ltd - 532649 - Disclosure As Per Regulation 30 Of The Securities And Exchange Of Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
24 Sep 2026 Trading Window Nectar Lifesciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
19 Sep 2026 Company Update Nectar Lifesciences Ltd - 532649 - Revised Proceedings Of 31St Annual General Meeting (''AGM'')
19 Sep 2026 General Updates Please find attached herewith Revised Proceedings of 31st Annual General Meeting
18 Sep 2026 AGM/EGM Nectar Lifesciences Ltd - 532649 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
18 Sep 2026 AGM/EGM Nectar Lifesciences Ltd - 532649 - Proceedings Of 31St Annual General Meeting ('AGM')
18 Sep 2026 Shareholders meeting Nectar Lifesciences Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 18, 2026. Further, the company has informed the Exchange regarding voting results.
18 Sep 2026 Shareholders meeting Nectar Lifesciences Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 18, 2026
22 Aug 2026 General Updates Please find attached herewith letter sent to the members pursuant to Regulation 36(1)(b)of the SEBI (LODR) Regulations, 2015.

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Low financial leverage (Debt/Equity 0.00)

Weaknesses

  • Low Return on Equity (-50.3%)
  • Thin net profit margin (1.7%)
  • Declining revenue YoY (-100.0%)

Opportunities

  • PEG below 1 (0.21) -- earnings growth outpacing its own valuation
  • Trading below book value (PB 0.35)

Threats

  • Down 25.6% over the past year
  • Weak interest coverage (0.4x) -- limited cushion against rising rates

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Nectar Lifesciences Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.